Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a rare scalp condition causing a thick scalp and hair loss didn't improve with steroid treatment.

Eclipta prostrata is a medicinal herb with potential health benefits for various conditions and could be used in modern medicine.

Many women with HIV in the North of England are diagnosed late and have other health conditions.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Genetic differences affect COVID-19 severity and treatment development.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Men have more severe COVID-19 outcomes than women.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Possible link between androgens and COVID-19 severity; more research needed.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.